Cargando…
Magnetic hyperthermia with ε-Fe(2)O(3) nanoparticles
Biocompatibility restrictions have limited the use of magnetic nanoparticles for magnetic hyperthermia therapy to iron oxides, namely magnetite (Fe(3)O(4)) and maghemite (γ-Fe(2)O(3)). However, there is yet another magnetic iron oxide phase that has not been considered so far, in spite of its unique...
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Royal Society of Chemistry
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055867/ https://www.ncbi.nlm.nih.gov/pubmed/35520081 http://dx.doi.org/10.1039/d0ra04361c |